Trials / Completed
CompletedNCT04028492
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
VP-VLY-686-3301: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Iii Study To Assess The Efficacy Of Tradipitant In Relieving Symptoms Of Gastroparesis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 992 (actual)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tradipitant | BID |
| DRUG | Placebo | BID |
| DRUG | Open Label Tradipitant | BID |
Timeline
- Start date
- 2019-08-20
- Primary completion
- 2025-02-21
- Completion
- 2025-02-21
- First posted
- 2019-07-22
- Last updated
- 2025-07-24
Locations
36 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04028492. Inclusion in this directory is not an endorsement.